Oura launches redesigned app and ‘Cumulative Stress’ feature
The company is seeking FDA clearance for new blood pressure features that assess users' likelihood of having hypertension.
MAIN POINTS
- The company is developing blood pressure features.
- These features provide a likelihood assessment of hypertension.
- FDA clearance is being pursued for these features.
- The goal is to enhance user health monitoring.
TAKEAWAYS
- FDA approval is crucial for the new features.
- Users will gain insights into their hypertension risk.
- The innovation aims to improve health management.
- Regulatory clearance is a key step in product development.